James O. Wilson

Array ( [id] => 1420252 [patent_doc_number] => 06514980 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Nucleoside analogs in combination therapy of herpes simplex infections' [patent_app_type] => B1 [patent_app_number] => 09/626015 [patent_app_country] => US [patent_app_date] => 2000-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2111 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514980.pdf [firstpage_image] =>[orig_patent_app_number] => 09626015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1562361 [patent_doc_number] => 06362329 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Process to prepare pyrimidine nucleosides' [patent_app_type] => B1 [patent_app_number] => 09/618783 [patent_app_country] => US [patent_app_date] => 2000-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2558 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/362/06362329.pdf [firstpage_image] =>[orig_patent_app_number] => 09618783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4307217 [patent_doc_number] => 06326491 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Process to prepare pyrimidine nucleosides' [patent_app_type] => 1 [patent_app_number] => 9/618247 [patent_app_country] => US [patent_app_date] => 2000-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2633 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326491.pdf [firstpage_image] =>[orig_patent_app_number] => 618247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420226 [patent_doc_number] => 06506736 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Method for obtaining and using a combination of a purine nucleotide and nitrogen monoxide donor for treating sexual dysfunction' [patent_app_type] => B1 [patent_app_number] => 09/614694 [patent_app_country] => US [patent_app_date] => 2000-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2462 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506736.pdf [firstpage_image] =>[orig_patent_app_number] => 09614694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1569710 [patent_doc_number] => 06497906 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-24 [patent_title] => 'Dietary supplements comprising soy hypocotyls containing at least one isoflavone' [patent_app_type] => B1 [patent_app_number] => 09/547100 [patent_app_country] => US [patent_app_date] => 2000-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7027 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/497/06497906.pdf [firstpage_image] =>[orig_patent_app_number] => 09547100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4311744 [patent_doc_number] => 06316421 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Pentaerythritol lipid derivatives and nuleic-acid complexes' [patent_app_type] => 1 [patent_app_number] => 9/536286 [patent_app_country] => US [patent_app_date] => 2000-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8990 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316421.pdf [firstpage_image] =>[orig_patent_app_number] => 536286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307872 [patent_doc_number] => 20020094963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'BENZIMIDAZOLE DERIVATIVES' [patent_app_type] => new [patent_app_number] => 09/424934 [patent_app_country] => US [patent_app_date] => 2000-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38349 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094963.pdf [firstpage_image] =>[orig_patent_app_number] => 09424934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1371596 [patent_doc_number] => 06566515 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Photocleavable protecting groups and methods for their use' [patent_app_type] => B1 [patent_app_number] => 09/525045 [patent_app_country] => US [patent_app_date] => 2000-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 9144 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566515.pdf [firstpage_image] =>[orig_patent_app_number] => 09525045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602745 [patent_doc_number] => 06432924 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase' [patent_app_type] => B1 [patent_app_number] => 09/493999 [patent_app_country] => US [patent_app_date] => 2000-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4552 [patent_no_of_claims] => 103 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432924.pdf [firstpage_image] =>[orig_patent_app_number] => 09493999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4362892 [patent_doc_number] => 06255478 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Nucleic acid extraction method' [patent_app_type] => 1 [patent_app_number] => 9/476379 [patent_app_country] => US [patent_app_date] => 2000-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 7141 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 293 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255478.pdf [firstpage_image] =>[orig_patent_app_number] => 476379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1490626 [patent_doc_number] => 06417173 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers' [patent_app_type] => B1 [patent_app_number] => 09/476158 [patent_app_country] => US [patent_app_date] => 1999-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 13075 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417173.pdf [firstpage_image] =>[orig_patent_app_number] => 09476158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4268782 [patent_doc_number] => 06306837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Heavy metal chelating agent for oral administration, its synthesis and its uses in medicine and health protection' [patent_app_type] => 1 [patent_app_number] => 9/473737 [patent_app_country] => US [patent_app_date] => 1999-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2845 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306837.pdf [firstpage_image] =>[orig_patent_app_number] => 473737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636281 [patent_doc_number] => 06380378 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Nucleotide compound, nucleotide block oligonucleotide, and method for producing them' [patent_app_type] => B1 [patent_app_number] => 09/471802 [patent_app_country] => US [patent_app_date] => 1999-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22514 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380378.pdf [firstpage_image] =>[orig_patent_app_number] => 09471802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586183 [patent_doc_number] => 06358963 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Antiviral nucleoside analogues' [patent_app_type] => B1 [patent_app_number] => 09/468813 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11410 [patent_no_of_claims] => 129 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358963.pdf [firstpage_image] =>[orig_patent_app_number] => 09468813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4316838 [patent_doc_number] => 06242592 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Process for the preparation of 2\'-O-alkyl-guanosine, cytidine, and uridine phosphoramidites' [patent_app_type] => 1 [patent_app_number] => 9/457788 [patent_app_country] => US [patent_app_date] => 1999-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18774 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242592.pdf [firstpage_image] =>[orig_patent_app_number] => 457788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1543030 [patent_doc_number] => 06372723 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Compositions and methods for preventing restenosis following revascularization procedures' [patent_app_type] => B1 [patent_app_number] => 09/456432 [patent_app_country] => US [patent_app_date] => 1999-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4940 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372723.pdf [firstpage_image] =>[orig_patent_app_number] => 09456432 [rel_patent_id] =>[rel_patent_doc_number] =>)